LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver.

Adv Mater · 2026 · PMC12862737 · PMID 41045103

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

LDI‐treated group exhibited a decreasing trend in AST, ALT, and total cholesterol levels when compared to both the control and pSiO 2 ‐treated groups without statistical significant (Figure S20 , Supporting Information).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.